The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated×5•Originally published 5 May 2026•Updated 7 May 2026•

1 min read

Devon Energy Completes Coterra Merger Amid Q1 Earnings Season

Key Facts

1Devon Energy reported earnings of $1.04 per share, beating the consensus estimate of $1 per share.

2Exelixis reported earnings of $0.87 per share, surpassing the estimated $0.75 per share.

3Silicon Laboratories posted earnings of $0.53 per share, beating the consensus estimate of $0.49.

3 months ago

Version History

3 additional sources confirmed this story

Version 53 months ago

What changed: The story was updated to include the official completion of the Devon Energy and Coterra Energy merger and the launch of a new shareholder capital return program.

Version 43 months ago

What changed: Added Q1 earnings results for Riley Exploration Permian (REPX), showing an earnings beat despite a year-over-year decline.

Version 33 months ago

What changed: Added Q1 earnings performance for Northwest Natural (NWN), showing a slight beat against analyst expectations.

Version 23 months ago

What changed: Updated the report to include Devon Energy's miss on sales and GAAP EPS expectations, while adding data on its free cash flow margin and production growth.

Version 13 months ago

What changed: Added specific Q1 earnings outperformance data for Occidental Petroleum (OXY) to the broader energy sector earnings narrative.

The energy sector landscape has shifted significantly as Devon Energy (DVN) officially completed its merger with Coterra Energy, marking a major strategic consolidation. Following the merger, the company launched an updated shareholder capital return program aimed at boosting investor confidence despite recent operational headwinds. These developments coincide with Riley Exploration Permian (REPX) reporting Q1 earnings of $1.02 per share, beating the $0.99 consensus estimate. While Devon previously struggled with a 16.1% year-on-year revenue decline, the new merger and capital strategy signal a pivot toward long-term stability. Meanwhile, firms like Exelixis and Silicon Laboratories continue to maintain robust performance, contributing to a complex but evolving earnings season for the industry.